Spire Healthcare Group PLC Announcement of Management Changes (9058H)

TIDMSPI

RNS Number : 9058H

Spire Healthcare Group PLC

13 June 2017

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Spire Healthcare Group plc

("Spire Healthcare", "the Company" or "the Group")

Announcement of Management Changes

13 June 2017

Spire Healthcare Group plc (LSE: SPI), one of the UK's leading independent hospital groups, announces that Garry Watts, the current Executive Chairman, has been diagnosed with a medical condition and is currently undergoing treatment as a result of which he may need some short periods out of the business over the next several months. As a consequence, while he will remain active and engaged in the Company's activities, he has indicated to the Board his decision to revert to his previous role as Non-Executive Chairman of Spire.

In light of the above change in Garry's role, the Group is today announcing the appointment of Simon Gordon, Spire's current Chief Financial Officer, as Interim Chief Executive Officer with immediate effect.

The post of Chief Financial Officer, also on an interim basis, will be taken by Andrew Goldsmith, who is currently Spire's Head of Finance. Andrew, who is a member of the Chartered Institute of Management Accountants, joined the Spire Group (then Bupa Hospitals) in April 2007.

Spire also confirms that a formal process is underway to identify and appoint a permanent Chief Executive Officer. The process is expected to include candidates from both inside and outside the Group.

Peter Bamford, Spire's Deputy Chairman & Senior Independent Director, said:

"I and the Board would like to thank Garry for all his hard work as Executive Chairman in the last year. Now that he is returning to his previous role as Non-Executive Chairman we are very fortunate to be able to appoint Simon Gordon as Interim CEO, since his tenure with the Company and previous interaction with our investors means he will move seamlessly into that role, while continuing to work closely with Garry. "

   -   End   - 

For further information please contact:

Spire Healthcare

Antony Mannion, Investor Relations Director

[phone]

Maitland

Neil Bennett / Tom Eckersley

[phone]

Registered office and head office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLIFSERRIVLID

(END) Dow Jones Newswires

June 13, 2017 02:01 ET (06:01 GMT)